Manuka honey inhibits adhesion and invasion of medically important wound bacteria in vitro

Future Microbiology

Volumn 8, Issue 12, 2013, Pages 1523-1536

  Maddocks, Sarah Elizabeth ^a   Jenkins, Rowena Eleri ^a   Rowlands, Richard Samuel ^a   Purdy, Kevin John ^b   Cooper, Rose Agnes ^a  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

biofilm; collagen; fibrinogen; fibronectin; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pyogenes

Indexed keywords

COLLAGEN; CRYSTAL VIOLET; FIBRINOGEN; FIBRONECTIN; GENTAMICIN; MEDIHONEY; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BIOFILM; CELL ADHESION; CELL DEATH; CELL INVASION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HONEY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KERATINOCYTE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PYOGENES; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOFILMS; DOWN-REGULATION; HONEY; HUMANS; KERATINOCYTES; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; WOUNDS AND INJURIES;

EID: 84889574782     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.126     Document Type: Article

References (55)

1. Gottrup F. Trends in surgical wound healing. Scand. J. Surg. 97, 220-226 (2008).
2. Werdin F, Tennenhaus M, Schaller H, Rennekampff H. Evidence based strategies for treatment of chronic wounds. J. Plast. Surg. 9, 169-179 (2008).
3. James GA, Swogger E, Wolcott R et al. Biofilms in chronic wounds. Wound Repair Regen. 16, 37-44 (2008).
4. Rhoads DD, Wolcott RD, Percival SL. Biofilms in wounds: Management strategies. J. Wound Care 17, 502-508 (2008).
5. Kreikemeyer B, Ga ́mez G, Margarit I et al. Genomic organization, structure, regulation and pathogenic role of pilus constituents in major pathogenic Streptococci and Enterococci. Int. J. Med. Microbiol. 301, 240-251 (2006).
6. Cooper RA, Molan PC, Harding KG. Antibacterial activity of honey against strains of Staphylococcus aureus from infected wounds. J. R. Soc. Med. 92, 283-285 (1999). (Pubitemid 29312959)
7. Cooper R, Molan P. The use of honey as an antiseptic in managing Pseudomonas infection. J. Wound Care 8, 161-164 (1999).
8. Henriques AF, Jenkins RE, Burton NF, Cooper RA. The intracellular effects of manuka honey on Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 29, 45-50 (2010).
9. Henriques AF, Jenkins RE, Burton NF, Cooper RA. The effect of manuka honey on the structure of Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis. 30, 167-171 (2011).
10. Jenkins R, Burton N, Cooper R. Effect of manuka honey of the expression of universal stress protein A in methicillin resistance Staphylococcus aureus. Int. J. Antimicrob. Agents 37, 373-376 (2011).
11. Jenkins R, Burton N, Cooper R. Manuka honey inhibits cell division in methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 66, 2536-2542 (2011).
12. Badet C, Quero F. The in vitro effect of manuka honeys on growth and adherence of oral bacteria. Anaerobe 17, 99-22 (2011).
13. Cooper RA, Lindsay E, Molan PC. Testing the susceptibility to manuka honey of streptococci isolated from wound swabs. J. Apiprod. Apimed. Sci. 3, 117-122 (2011).
14. Maddocks SE, Salinas Lopez M, Rowlands RS, Cooper RA. Manuka honey inhibits the development of biofilms of Streptococcus pyogenes and causes reduced expression of two fibronectin binding proteins. Microbiology 158, 781-790 (2012).
15. Andrews J. British Society for Antimicrobial Chemotherapy Methods for Antimicrobial Susceptibility Testing. British Society for Antimicrobial Chemotherapy, Birmingham, UK (2011).
16. Merritt JH, Kadouri DE, O'Toole GA. Growing and analyzing static biofilms. Curr. Protoc. Microbiol. 22, 1B1.1-1B1.17 (2011).
17. Jakubovics NS, Kerrigan SW, Nobbs AH et al. Functions of cell surface-Anchored antigen I/II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors. Infect. Immun. 73, 6629-6638 (2005). (Pubitemid 41368828)
18. Jakubovics NS, Brittan JL, Dutton LC, Jenkinson HF. Multiple adhesin proteins on the cell surface of Streptococcus gordonii are involved in adhesion to human fibronectin. Microbiology 155, 3572-3580 (2009).
19. Rasigade JP, Moulay A, Lhoste Y et al. Impact of sub-inhibitory antibiotics on fibronectin-mediated host cell adhesion and invasion by Staphylococcus aureus. BMJ 11, 263 (2011).
20. Miles AA, Misra SS, Irwin JO. The estimation of the bacterial power of the blood. J. Hyg. 38, 732-749 (1938).
21. Unnanuntana A, Bonsignore L, Shirtliff ME, Greenfield EM. The effects of farnesol on Staphylococcus aureus biofilms and osteoblasts. J. Bone Joint. Surg. 91, 2683-2692 (2009).
22. Secor PR, James JA, Fleckman P, Olerud JE, McInnerney K, Stewart PS. Staphylococcus aureus biofilm and planktonic cultures differentially impact gene expression, mapK phosphorylation, and cytokine production in human keratinocytes. BMJ Microbiol. 11, 143-156 (2011).
23. Gruszka DT, Wojdyla JA, Bingham RJ et al. Staphylococcal biofilm-forming protein has a contiguous rod-like structure. Proc. Natl Acad. Sci USA 109, e1011-e1018 (2012).
24. Mann EE, Rice KC, Boles BR et al. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PloS ONE 6, e5822 (2009).
25. Oliver-Kozup HA, Elliott M, Bachert BA et al. The streptococcal collagen-like protein-1 (Scl1) is a significant determinant for biofilm formation by group a Streptococcus. BMC Microbiol. 11, 262-275 (2011).
26. Archer NK, Mazaitis MJ, Costerton JW, Leid JL, Powers ME, Shirtliff ME. Staphylococcus aureus biofilms properties, regulation and roles in human disease. Virulence 2, 445-459 (2011).
27. Kostenko V, Lyczak J, Turner K, Martinuzzi RJ. Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob. Agents Chemother. 54, 5120-5131 (2010).
28. Sjollema J, Rustema-Abbing M, van der Mei HC, Busscher HJ. Generalized relationship between numbers of bacteria and their viability in biofilms. Appl. Env. Microbiol. 77, 5027-5029 (2011).
29. Roberts AE, Maddocks SE, Cooper RA. Manuka honey is bactericidal against Pseudomonas aeruginosa and results in differential expression of oprF and algD. Microbiology 158, 3005-3013 (2012).
30. Otto M. Staphylococcal biofilms. Bacterial Biofilms. Curr. Topics Microbiol. Immunol. 322, 207-228 (2008).
31. Periasamy S, Joo H, Duong AC et al. How Staphylococcus aureus biofilms develop their characteristic structure. Proc. Natl Acad. Sci. USA 109, 1281-1286 (2011).
32. Stewart PS. Diffusion in biofilms. J. Bacteriol. 185, 1485-1490 (2003).
33. Dunne WM, Mason EO, Kaplan SL. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother. 37, 2522-2526 (1993). (Pubitemid 23357840)
34. Walters MC, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47, 317-323 (2003). (Pubitemid 36070381)
35. Jenkins R, Cooper R. Improving antibiotic activity against wound pathogens with manuka honey in vitro. PLoS ONE 7, e45600 (2012).
36. Merckoll P, Jonassen TØ, Vad ME, Jeansson SL, Melby KK. Bacteria, biofilm and honey: A study of the effects of honey on 'planktonic' and biofilm-embedded chronic wound bacteria. Scand. J. Infect. Dis. 41, 341-347 (2009).
37. Trafny E, Stepinska M, Antos M, Grzybowski J. Effects of free and liposome-encapsulated antibiotics on adherence of Pseudomonas aeruginosa to collagen type I. Antimicrob. Agents Chemother. 39, 2645-2649 (1995).
38. Hussain M, Haggar A, Peters G, Chhatwal GS. More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation. Infect. Immun. 76, 5615-5623 (2008).
39. Gillaspy AF, Lee CY, Sau S, Cheung AL, Smeltzer MS. Factors affecting the collagen binding capacity of Staphylococcus aureus. Infect. Immun. 66, 3170-3178 (1998). (Pubitemid 28303113)
40. Passali D, Lauriello GC, Pasali FM, Passali L. Group A Streptococcus and its antibiotic resistance. Acta Otorhinolaryngol. Ital. 27, 27-32 (2002).
41. Plotkowski MC, de Bentzmann S, Pereira SH et al. Pseudomonas aeruginosa internalization by human epithelial respiratory cells depends on cell differentiation, polarity, and junctional complex integrity. Am. J. Respir. Cell Mol. Biol. 20, 880-890 (1992).
42. Ahmed S, Megji S, Williams RJ, Henderson B, Brock JH, Nair SP. Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria. Infect. Immun. 69, 2872-2877 (2001). (Pubitemid 32332177)
43. Haggar A, Hussain M, Lonnies, H, Herrmann M, Norrby-Teglund A, Flock J. Extracellular adherence protein from Staphylococcus aureus enhances internalization into eukaryotic cells Infect. Immun. 71, 2310-2317 (2003). (Pubitemid 36519840)
44. Holderbaum D, Hall GS, Ehrhart LA. Collagen binding to Staphylococcus aureus. Infect. Immun. 54, 359-364 (1986). (Pubitemid 17171445)
45. Vaudaux PE, Monzillo V, Francois P, Lew DP, Foster TJ, Berger-Bachi B. Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob. Agents Chemother. 42, 564-570 (1998). (Pubitemid 28114809)
46. Houston P, Rowe SE, Pozzi C, Waters EM, O'Gara JP. Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype. Infect. Immun. 79, 1153-1165 (2011).
47. Kluftinger JL, Kelly NM, Jost H, Hancock RE. Fibronectin as an enhancer of nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages. Infect. Immun. 57, 2782-2785 (1989). (Pubitemid 19212612)
48. Lerrer B, Zinger-Yosovich KD, Avrahami B, Gilboa-Garber N. Honey and royal jelly, like human milk, abrogate lectin-dependent infection-preceding Pseudomonas aeruginosa adhesion. ISME J. 2, 149-155 (2007). (Pubitemid 46878157)
49. Proctor RA, Olbrantz PJ, Mosher DF. Subinhibitory concentrations of antibiotics alter fibronectin binding to Staphylococcus aureus. Antimicrob. Agents Chemother. 24, 823-826 (1983). (Pubitemid 14203892)
50. Nobbs AH, Lamont RJ, Jenkinson HF. Streptococcus adherence and colonization. Microbiol. Mol. Biol. Rev. 73, 407-450 (2009).
51. Burke FM, McCormack N, Rindi S, Speziale P, Foster TJ. Fibronectin-binding protein B variation in Staphylococcus aureus. BMC Microbiol. 10, 160-175 (2010).
52. Kisich KO, Howell MD, Boguniewicz M, Heizer HR, Watson NU, Leung DY. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on b-defensin 3. J. Invest. Dermatol. 127, 2368-2380 (2007). (Pubitemid 47619743)
53. Angus AA, Lee AA, Augustin DK, Lee EJ, Evans DJ, Fleiszig SM. Pseudomonas aeruginosa induces membrane blebs in epithelial cells, which are utilized as a niche for intracellular replication and motility. Infect. Immun. 76, 1992-2001 (2008). (Pubitemid 351656131)
54. Han A, Zenilman JM, Melendez JH et al. The importance of a multifaceted approach to characterizing the microbial flora of chronic wounds. Wound Repair Regen. 19, 532-541 (2011).
55. Dalton T, Dowd SE, Wolcott RD et al. An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS ONE 6, e27317 (2001).